Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001781571 | SCV002018273 | pathogenic | not provided | 2019-09-18 | criteria provided, single submitter | clinical testing | |
Knight Diagnostic Laboratories, |
RCV000193542 | SCV000223940 | likely pathogenic | Nemaline myopathy 2 | 2014-10-01 | no assertion criteria provided | clinical testing |